Reversing a Model of Parkinson's Disease With In Situ Converted Nigral Neurons

Affiliations

¹ Functional Neurosurgery, Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel.
² Department of Neurobiology, Hebrew University of Jerusalem, Jerusalem, Israel.

Comment

Zvi Israel et al. Mov Disord. 2020 Nov.

. 2020 Nov;35(11):1955.

doi: 10.1002/mds.28306. Epub 2020 Oct 5.

¹ Functional Neurosurgery, Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel.
² Department of Neurobiology, Hebrew University of Jerusalem, Jerusalem, Israel.

No abstract available

Comment on

Reversing a model of Parkinson's disease with in situ converted nigral neurons.
Qian H, Kang X, Hu J, Zhang D, Liang Z, Meng F, Zhang X, Xue Y, Maimon R, Dowdy SF, Devaraj NK, Zhou Z, Mobley WC, Cleveland DW, Fu XD. Qian H, et al. Nature. 2020 Jun;582(7813):550-556. doi: 10.1038/s41586-020-2388-4. Epub 2020 Jun 24. Nature. 2020. PMID: 32581380 Free PMC article.

1. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344(10):710-719.
1. Pfisterer U, Kirkeby A, Torper O, et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A 2011;108(25):10343-10348.
1. Addis RC, Hsu FC, Wright RL, et al. Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One 2011;6(12):e28719.
1. Rivetti di Val Cervo P, Romanov RA, Spigolon G, et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nat Biotechnol 2017;35(5):444-452.
1. Qian H, Kang X, Hu J, et al. Reversing a model of Parkinson's disease with in situ converted nigral neurons. Nature 2020;582(7813):550-556.